Animal-free source
Recombinant human albumin that removes dependence on human plasma as a starting material.
Animal-free recombinant human albumin and albumin-fusion technology on our proprietary Srbumin platform, available for licensing and supply.
Srbumin is Shilpa Biologicals’ proprietary recombinant human albumin and albumin-fusion platform: an animal-free albumin source and a novel biologics platform available for licensing and supply.
Because it is produced recombinantly rather than fractionated from donated plasma, Srbumin gives partners a consistent, traceable albumin supply, developed and manufactured on our integrated biologics campus in Dharwad, India, under one quality system.
The same albumin-fusion technology also enables novel biologics and next-generation therapeutics, so partners can work with us on supply, licensing or new molecules.
Recombinant human albumin that removes dependence on human plasma as a starting material.
A proprietary albumin-fusion platform that enables novel biologics and next-generation therapeutics.
Available to partners worldwide for licensing and for commercial supply.
Developed and manufactured on one integrated biologics campus, under one quality system.
Recombinant human albumin is a versatile protein across biopharmaceutical development and manufacturing.
An excipient that helps stabilise therapeutic proteins and vaccines in formulation.
A defined, animal-free supplement for cell culture, including cell and gene therapy manufacturing.
Fusion to albumin to extend the circulating half-life of therapeutic proteins and peptides.
A carrier for drug delivery and a coating for medical devices and lab consumables.
Licensing, supply and partnership enquiries for recombinant human albumin.
Sr. Business Development Manager, Recombinant Albumin – US
Biologics – rHA & CDMO UK/EU
Tell us about your program and our recombinant albumin team will respond at the earliest.
